Literature DB >> 20922213

Impact of linker length on the activity of PROTACs.

Kedra Cyrus1, Marie Wehenkel, Eun-Young Choi, Hyeong-Jun Han, Hyosung Lee, Hollie Swanson, Kyung-Bo Kim.   

Abstract

Conventional genetic approaches have provided a powerful tool in the study of proteins. However, these techniques often preclude selective manipulation of temporal and spatial protein functions, which is crucial for the investigation of dynamic cellular processes. To overcome these limitations, a small molecule-based novel technology termed "PROteolysis TArgeting ChimeraS (PROTACs)" has been developed, targeting proteins for degradation at the post-translational level. Despite the promising potential of PROTACs to serve as molecular probes of complex signaling pathways, their design has not been generalized for broad application. Here, we present the first generalized approach for PROTAC design by fine-tuning the distance between the two participating partner proteins, the E3 ubiquitin ligase and the target protein. As such, we took a chemical approach to create estrogen receptor (ER)-α targeting PROTACs with varying linker lengths and the loss of the ER in cultured cells was monitored via western blot and fluorometric analyses. We found a significant effect of chain length on PROTAC efficacy, and, in this case, the optimum distance between the E3 recognition motif and the ligand was a 16 atom chain length. The information gathered from this experiment may offer a generalizable PROTAC design strategy to further the expansion of the PROTAC toolbox, opening new possibilities for the broad application of the PROTAC strategy in the study of multiple signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922213      PMCID: PMC3835402          DOI: 10.1039/c0mb00074d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  25 in total

Review 1.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  From knowing to controlling: a path from genomics to drugs using small molecule probes.

Authors:  Robert L Strausberg; Stuart L Schreiber
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

3.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 5.  Deciphering isozyme function: exploring cell biology with chemistry in the post-genomic era.

Authors:  C M Crews
Journal:  Chem Biol       Date:  1996-12

6.  Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.

Authors:  F F Zheng; S D Kuduk; G Chiosis; P N Münster; L Sepp-Lorenzino; S J Danishefsky; N Rosen
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  Synthesis and evaluation of geldanamycin-estradiol hybrids.

Authors:  S D Kuduk; F F Zheng; L Sepp-Lorenzino; N Rosen; S J Danishefsky
Journal:  Bioorg Med Chem Lett       Date:  1999-05-03       Impact factor: 2.823

Review 8.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

9.  Chemical genetic control of protein levels: selective in vivo targeted degradation.

Authors:  John S Schneekloth; Fabiana N Fonseca; Michael Koldobskiy; Amit Mandal; Raymond Deshaies; Kathleen Sakamoto; Craig M Crews
Journal:  J Am Chem Soc       Date:  2004-03-31       Impact factor: 15.419

Review 10.  The ubiquitin system, disease, and drug discovery.

Authors:  Matthew D Petroski
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

View more
  32 in total

Review 1.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

2.  HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.

Authors:  Dennis L Buckley; Kanak Raina; Nicole Darricarrere; John Hines; Jeffrey L Gustafson; Ian E Smith; Afjal H Miah; John D Harling; Craig M Crews
Journal:  ACS Chem Biol       Date:  2015-06-23       Impact factor: 5.100

Review 3.  Targeted Protein Degradation: from Chemical Biology to Drug Discovery.

Authors:  Philipp M Cromm; Craig M Crews
Journal:  Cell Chem Biol       Date:  2017-06-22       Impact factor: 8.116

4.  PROTAC-induced proteolytic targeting.

Authors:  Kimberly Cornish Carmony; Kyung-Bo Kim
Journal:  Methods Mol Biol       Date:  2012

5.  Scaffold hopping enables direct access to more potent PROTACs with in vivo activity.

Authors:  George M Burslem; Daniel P Bondeson; Craig M Crews
Journal:  Chem Commun (Camb)       Date:  2020-06-23       Impact factor: 6.222

6.  Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader.

Authors:  Frances Potjewyd; Anne-Marie W Turner; Joshua Beri; Justin M Rectenwald; Jacqueline L Norris-Drouin; Stephanie H Cholensky; David M Margolis; Kenneth H Pearce; Laura E Herring; Lindsey I James
Journal:  Cell Chem Biol       Date:  2019-12-09       Impact factor: 8.116

7.  A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders.

Authors:  Ka Yang; Yu Zhao; Xueqing Nie; Hao Wu; Bo Wang; Chelsi M Almodovar-Rivera; Haibo Xie; Weiping Tang
Journal:  Cell Chem Biol       Date:  2020-05-14       Impact factor: 8.116

8.  MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53.

Authors:  John Hines; Schan Lartigue; Hanqing Dong; Yimin Qian; Craig M Crews
Journal:  Cancer Res       Date:  2018-11-01       Impact factor: 12.701

9.  Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.

Authors:  Nan Bai; Sven A Miller; Grigorii V Andrianov; Max Yates; Palani Kirubakaran; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-02-24       Impact factor: 4.956

10.  PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes.

Authors:  Joshua P Smalley; Grace E Adams; Christopher J Millard; Yun Song; James K S Norris; John W R Schwabe; Shaun Michael Cowley; James T Hodgkinson
Journal:  Chem Commun (Camb)       Date:  2020-04-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.